A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea

Completed · Phase 2

Conditions studied: Rosacea

In brief

To compare the efficacy and safety of tretinoin gel 0.05% to its vehicle when dosed once or twice daily in female subjects with rosacea.

Key facts

Study ID

NCT00621218

Run by

Coria Laboratories, Ltd.

People needed

36

Starts

2008-02-01

Expected to finish

2008-12-01

Last updated by the study team

2008-12-18

Who can join

Age: 18 and older, up to 65. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female
• Age 18-65
• Diagnosed with classical, centrofacial, erythemato-telangiectatic rosacea

You may not qualify if…

• Male, females less than 18 years
• Females over 65 years
• No diagnosed rosacea

Where it is running

• Product Investigations, Inc. — Conshohocken, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.